CD70 and neoplasm: It is therefore possible that sub-populations of RMC tumor cells expressing CD70 trigger hyperstimulation of B cells into a tumor-promoting, imbalanced antibody-producing plasma cell state, and in that way evade an effective immune response (Figure 4D).